Camlin Fine Sciences Limited (NSE:CAMLINFINE)
302.10
+1.81 (0.60%)
Jun 13, 2025, 3:30 PM IST
Camlin Fine Sciences Revenue
In the fiscal year ending March 31, 2025, Camlin Fine Sciences had annual revenue of 16.67B INR with 3.31% growth. Camlin Fine Sciences had revenue of 4.37B in the quarter ending March 31, 2025, with 8.90% growth.
Revenue
16.67B
Revenue Growth
+3.31%
P/S Ratio
3.41
Revenue / Employee
26.71M
Employees
624
Market Cap
56.82B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 16.67B | 534.65M | 3.31% |
Mar 31, 2024 | 16.13B | -685.02M | -4.07% |
Mar 31, 2023 | 16.82B | 2.69B | 19.08% |
Mar 31, 2022 | 14.12B | 2.25B | 18.95% |
Mar 31, 2021 | 11.87B | 1.38B | 13.15% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UltraTech Cement | 759.55B |
Asian Paints | 338.59B |
Grasim Industries | 1,484.78B |
Vedanta | 1,507.25B |
Pidilite Industries | 131.40B |
Solar Industries India | 75.40B |
Shree Cement | 192.83B |
Jindal Steel & Power | 497.65B |
Camlin Fine Sciences News
- 4 months ago - Camlin Fine Sciences Q3 FY25 results: Revenue rises 8.7% YoY to Rs 435.5 crore, net loss at Rs 158.2 crore - Business Upturn
- 4 months ago - Top stocks to buy today: Stock recommendations for February 7, 2025 - The Times of India